News
Ministry of Chemicals & Fertilizers, has extended the deadline for submitting applications under the Production Linked ...
The president announced the addition of 80 essential pharmaceuticals with significant discounts. There are now 110 pharmacies ...
DoP extends timeline to apply for 11 bulk drugs under PLI scheme: Our Bureau, New Delhi Wednesday, June 18, 2025, 08:00 Hrs [IST] The Department of Pharmaceuticals (DoP) has exten ...
Daré Bioscience stockholders as of close of business on the April 17, 2025 record date for the Annual Meeting, or their legal ...
DBT to support biomanufacturing of APIs to reduce GHG emissions: Gireesh Babu, New Delhi Monday, June 16, 2025, 08:00 Hrs [IST] The Department of Biotechnology (DBT) is planning t ...
Jill Feldman discusses the background of the phase 2 COCOON trial in advanced non–small cell lung cancer with EGFR mutations.
Hydrocephalus, characterized by excessive cerebrospinal fluid in the brain, affects over 1 million people in the United States. Shunt therapy, the most common treatment, 2 often comes with the risk of ...
11d
News-Medical.Net on MSNWhen old diseases find new ways in: Europe’s latest diphtheria outbreak explainedA large multicountry outbreak of toxigenic Corynebacterium diphtheriae occurred among migrants entering Europe in 2022, ...
This medicine is available only with a doctor's prescription. Do not use Dalacin V Cream if you have an allergy to clindamycin or lincomycin or any of the ingredients in Dalacin V Cream listed at ...
The first FDA-approved product to emerge from Daré’s portfolio of women’s health product candidates is XACIATO™ (clindamycin phosphate) vaginal gel 2%, a lincosamide antibacterial indicated for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results